WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP Research Development2025-08-192,000$10.60
$21.20kBuy
Fady Ibraham MalikEVP Research Development2025-08-192,000$38.31
$76.62kSell
Robert I. BlumPresident CEO2025-08-155,000$38.42
$192.10kSell
Fady Ibraham MalikEVP Research Development2025-08-052,000$10.60
$21.20kBuy
Fady Ibraham MalikEVP Research Development2025-08-052,000$36.34
$72.68kSell
Robert I. BlumPresident CEO2025-07-295,000$36.45
$182.25kSell
Fady Ibraham MalikEVP Research Development2025-07-222,000$10.60
$21.20kBuy
Fady Ibraham MalikEVP Research Development2025-07-222,000$37.47
$74.94kSell
Wendall WierengaDirector2025-07-15164$38.01
$6.23kBuy
John T. HendersonDirector2025-07-15559$38.01
$21.25kBuy

1 of 15

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc14.74%17,602,440$674.88MInstitution
Blackrock Inc13.13%15,677,867$601.09MInstitution
Vanguard Group Inc10.03%11,983,838$459.46MInstitution
Fmr LLC9.43%11,267,511$432.00MInstitution
Michael Schmertzler8.15%9,730,131$373.05MInsider
Wellington Management Group LLP6.55%7,827,679$300.11MInstitution
State Street Corp5.34%6,372,753$244.33MInstitution
Deep Track Capital LP3.06%3,650,000$139.94MInstitution
Ubs Group Ag2.57%3,070,665$117.73MInstitution
Geode Capital Management LLC2.51%2,994,445$114.81MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK90.08%9.92%Net SellingNet Selling
TGTX56.40%43.60%Net SellingNet Selling
KRYS78.73%21.27%Net SellingNet Selling
ACAD72.41%27.59%Net SellingNet Selling
ABVX48.35%0.00%
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 115.53% institutional shareholders, 12.72% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 8.15% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $373.05M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.